InsiderDB

SEC EDGAR · Company announcement

ABBV: Financial results

Filed 8-K for an event or period dated 2026-07-31. Financial results.

Follow ABBV
Became public
Jul 31, 2026, 7:51 AM EDT
Event / period date
Jul 31, 2026
Collected
Nov 9, 2026, 1:46 PM EST

Why this is connected

This filing identifies AbbVie Inc. as the issuer of the security. The company's SEC identifier connects it to ABBV.

Press Release dated ↗

Source evidence

Read the source excerpt or record
Item 2.02 Results of Operations and Financial Condition On July 31, 2026, AbbVie Inc. issued a press release announcing financial results for the second quarter ended June 30, 2026. A copy of the press release is furnished as Exhibit 99.1 to this report and incorporated herein by reference. Item 9.01 Financial Statements and Exhibits (d) Exhibits Exhibit No. Exhibit 99.1 Press Release dated Jul y 31 , 2026 (furnished pursuant to Item 2.02). 104 The cover page from this Current Report on Form 8-K formatted in Inline XBRL (included as Exhibit 101). SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ABBVIE INC. Date: July 31, 2026 By: /s/ Scott T. Reents Scott T. Reents Executive Vice President, Chief Financial Officer

Price change after we could observe it

+0.37% ABBV

Adjusted closing prices from Nov 10, 2026 to Nov 11, 2026. SPY changed 1.32% over the same dates. The start is the first available close after both publication and collection. This is a price comparison, not an executed trade, investor profit, or a backtested strategy.

Congressional trading in ABBV

These disclosures provide context. Their presence does not establish a link between a trader and the event.

Original documents control. Public records can be amended, and company connections may require interpretation. Nothing here is investment advice.